HomeAboutScientific TeamCode of Good PracticeResearchCOVID-19 TestingCardiac HealthClinical Trial Design & MethodologyHepatologyEthnic and Sex Differences Physiology & Drug ResponsesPublicationsNewsCareersSupportContact

Accelerating Breakthroughs in Medical Research

We are Richmond Research Institute – an independent, not-for-profit, academic research unit dedicated to clinical trial safety optimisation.

COVID-19 Testing

Testing for COVID-19 is crucial to understand who is infected and therefore a risk to others by spreading the infection.

Summary of results

Number of people tested

4,623

4,623 people were tested between 1 to 254 times

407 staff
3,341 Volunteers

Number of Tests

34,965

PCR Tests

14,296

Antibody Tests

See the full results

Our academic research is focused on the key areas of Clinical Trial Methodology and Precision Medicine.

We use the following methodologies to address scientific questions and gain valuable insights within these areas. 

Learn more about Richmond Research Institute

Conducted research

Our research aims to gather physiological data, interrogate large datasets and investigate precision medicine approaches, to gain valuable scientific insights.

richmond research institute

We have a track record in conducting clinical research.

Publications

We present our scientific findings at meetings.

Videos

Our academic research helps improve lives and strengthens scientific insights.

Research

We work with partners at the following organisations: 

We are Richmond Research Institute - an independent, academic research unit dedicated to clinical trial safety optimisation.

Our academic research is focused on four key areas:

Cardiac sciences including basic electrophysiology

Drug-induced hepatic injury

Ethnic and sex differences in human physiology

Improvement of clinical trial methodologies to fast-track early patient access to new medicines

Learn more about Richmond Research Institute

COVID-19 Testing

Testing for COVID-19 is crucial to understand who is infected and therefore a risk to others by spreading the infection.

Summary of results

Number of people tested

4,623

4,623 people were tested between 1 to 254 times

407 staff
3,341 Volunteers

Number of Tests

34,965

PCR Tests

14,296

Antibody Tests

See the full results

Can a second booster dose be delayed in patients who have had COVID-19?

Individuals who were previously infected produced significantly more antibodies, more rapidly. This information could inform the prioritisation of vaccine administration.

Watch the video below to learn more

Conducted research

Our research aims to utilise various methodologies to gather physiological data, interrogate large datasets and investigate precision medicine approaches, to gain valuable scientific insights.

richmond research institute

We have a track record in conducting clinical research.

Publications

We present our scientific findings at meetings.

Videos

Our academic research helps improve lives and strengthens scientific insights.

Research

We work with partners at the following organisations: